US2002042933A1PendingUtilityA1
Omega-3 fatty acid desaturase
Priority: Feb 18, 1997Filed: Dec 20, 2000Published: Apr 11, 2002
Est. expiryFeb 18, 2017(expired)· nominal 20-yr term from priority
C12N 9/0014C12N 9/0083C12N 15/8247
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Recombinant expression of fat-1 gene of Caenorhabditis elegans in a wide variety of cells, including cells of Arabidopsis thaliana and Saccharomyces cerevisiae , produces a polypeptide having ω-3 desaturase activity.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A cell comprising a recombinant FAT-1 polypeptide that desaturates an ω-6 fatty acid to a corresponding ω-3 fatty acid.
2 . The cell of claim 1 wherein the ω-6 fatty acid has a carbon chain of at least 18 carbons.
3 . The cell of claim 2 wherein the ω-6 fatty acid is a 20-carbon ω-6 fatty acid or a 22-carbon ω-6 fatty acid.
4 . The cell of claim 1 wherein the ω-6 fatty acid has a double bond at one or more positions selected from the group consisting of Δ4, Δ5, Δ6, Δ7, and Δ8.
5 . The cell of claim 1 having a proportion of ω-3 fatty acids that is at least 10% greater than an otherwise similar cell lacking the recombinant FAT-1 polypeptide.
6 . The cell of claim 5 having a proportion of ω-3 fatty acids that is at least 20% greater than an otherwise similar cell lacking the recombinant FAT-1 polypeptide.
7 . The cell of claim 6 having a proportion of ω-3 fatty acids that is at least 50% greater than an otherwise similar cell lacking the recombinant FAT-1 polypeptide.
8 . The cell of claim 1 wherein the ω-6 fatty acid has a carbon chain of at least 20 carbons and at least 25% of the ω-6 fatty acid is desaturated to the corresponding ω-3 fatty acid.
9 . The cell of claim 1 wherein the recombinant FAT-1 polypeptide has at least 60% amino acid sequence identity with the FAT-1 polypeptide of SEQ ID NO:1.
10 . The cell of claim 1 wherein the recombinant FAT-1 polypeptide has at least 70% amino acid sequence identity with the FAT-1 polypeptide of SEQ ID NO:1.
11 . The cell of claim 10 wherein the recombinant FAT-1 polypeptide has at least 80% amino acid sequence identity with the FAT-1 polypeptide of SEQ ID NO:1.
12 . The cell of claim 10 wherein the recombinant FAT-1 polypeptide has at least 90% amino acid sequence identity with the FAT-1 polypeptide of SEQ ID NO:1.
13 . The cell of claim 1 wherein the recombinant FAT-1 polypeptide has only conservative amino acid substitutions to the FAT-1 polypeptide of SEQ ID NO:1.
14 . The cell of claim 1 wherein the recombinant FAT-1 polypeptide has 100% amino acid sequence identity with the FAT-1 polypeptide of SEQ ID NO:1.
15 . The cell of claim 1 wherein the recombinant FAT-1 polypeptide is encoded by a polynucleotide that comprises a sequence having at least 70%s nucleotide sequence identity with the fat-1 polynucleotide sequence of SEQ ID NO:1.
16 . The cell of claim 15 wherein the polynucleotide comprises a sequence having at least 80% nucleotide sequence identity with the fat-1 polynucleotide sequence of SEQ ID NO:1.
17 . The cell of claim 15 wherein the polynucleotide comprises a sequence having at least 90% nucleotide sequence identity with the fat-1 polynucleotide sequence of SEQ ID NO:1.
18 . The cell of claim 15 wherein the polynucleotide comprises a sequence having 100% nucleotide sequence identity with the fat-1 polynucleotide sequence of SEQ ID NO:1.
19 . The cell of claim 1 wherein the polypeptide is encoded by a polynucleotide comprising a full-length native fat-1 protein-coding region.
20 . A cell of claim 1 of an organism selected from the group consisting of a bacterium, a cyanobacterium, a phytoplankton, an alga, a fungus, a plant, and an animal.
21 . A lipid from the cell of claim 1 .
22 . The lipid of claim 21 wherein at least 25% of an ω-6 fatty acid of the cell having a carbon chain of at least 20 carbons has been converted to a corresponding ω-3 fatty acid by the FAT-1 polypeptide.
23 . A transgenic plant comprising a fat-1 polynucleotide that is expressible in at least a part of the plant.
24 . The transgenic plant of claim 23 wherein the fat-1 polynucleotide is expressible in a seed of the plant.
25 . A seed of the transgenic plant of claim 23 .
26 . A lipid from the transgenic plant of claim 23 that has a higher proportion of ω-3 fatty acids than a control lipid obtained from an otherwise similar plant lacking the fat-1 polynucleotide.
27 . A method of desaturating an ω-6 fatty acid to a corresponding ω-3 fatty acid comprising the steps of:
(a) providing a cell that comprises a recombinant FAT-1 polypeptide; and
(b) growing the cell under conditions under which the FAT-1 polypeptide desaturates an ω-6 fatty acid to produce a corresponding ω-3 fatty acid.
28 . The method of claim 27 wherein the ω-6 fatty acid is an ω-6 fatty acid having a carbon chain of at least 18 carbons.
29 . The method of claim 28 wherein the ω-6 fatty acid is a 20-carbon ω-6 fatty acid or a 22-carbon ω-6 fatty acid.
30 . The method of claim 27 wherein the ω-6 fatty acid comprises a double bond at one or more positions selected from the group consisting of Δ4, Δ5, Δ6, Δ7, and Δ8.
31 . The method of claim 27 wherein the recombinant polypeptide has at least 60% amino acid sequence identity with the FAT-1 polypeptide of SEQ ID NO:1.
32 . The method of claim 27 wherein the recombinant polypeptide has at least 70% amino acid sequence identity with the FAT-1 polypeptide of SEQ ID NO:1.
33 . The method of claim 32 wherein the recombinant polypeptide has at least 80% amino acid sequence identity with the FAT-1 polypeptide of SEQ ID NO:1.
34 . The method of claim 32 wherein the recombinant polypeptide has at least 90% amino acid sequence identity with the FAT-1 polypeptide of SEQ ID NO:1.
35 . The method of claim 32 wherein the recombinant polypeptide has only conservative amino acid substitutions to the FAT-1 polypeptide of SEQ ID NO:1.
36 . The method of claim 32 wherein the recombinant polypeptide has 100% amino acid sequence identity with the FAT-1 polypeptide of SEQ ID NO:1.
37 . The method of claim 27 wherein the FAT-1 polypeptide is encoded by a recombinant polynucleotide that comprises a sequence having at least 70% nucleotide sequence identity with the fat-1 polynucleotide sequence of SEQ ID NO:1.
38 . The method of claim 37 wherein the polynucleotide comprises a sequence having at least 80% nucleotide sequence identity with the fat-1 polynucleotide sequence of SEQ ID NO:1.
39 . The method of claim 37 wherein the polynucleotide comprises a sequence having at least 90% nucleotide sequence identity with the fat-1 polynucleotide sequence of SEQ ID NO:1.
40 . The method of claim 37 wherein the polynucleotide comprises a sequence having 100% nucleotide sequence identity with the fat-1 polynucleotide sequence of SEQ ID NO:1.
41 . The method of claim 27 wherein the polypeptide is encoded by a polynucleotide that comprises a full-length native fat-1 protein-coding region.
42 . A method of claim 27 wherein the cell is a cell of an organism selected from the group consisting of a bacterium, a cyanobacterium, a phytoplankton, an alga, a fungus, a plant, and an animal.
43 . The method of claim 42 wherein the cell is a plant cell.
44 . The method of claim 42 wherein the cell is a yeast cell.
45 . A method of producing a lipid comprising an ω-3 fatty acid comprising the steps of:
(a) providing a lipid that comprises an ω-6 fatty acid; and
(b) desaturating at least some of the ω-6 fatty acid to a corresponding ω-3 fatty acid with a recombinant FAT-1 polypeptide.
46 . The method of claim 45 wherein the lipid comprises an ω-6 fatty acid having a carbon chain of at least 20 carbons, the method comprising desaturating at least 25% of the ω-6 fatty acid to the corresponding ω-3 fatty acid.
47 . The method of claim 45 comprising the step of expressing a recombinant fat-1 polynucleotide in a cell comprising the lipid, thereby producing the recombinant FAT-1 polypeptide in the cell.Join the waitlist — get patent alerts
Track US2002042933A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.